Gritstone bio Presents Improvements to EDGE™ Platform at AACR 2024
-- State-of-the-art neoantigen prediction platform now predicts HLA Class I presentation of epitopes with
Stay updated with breaking news from Positive Predictive Value. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- State-of-the-art neoantigen prediction platform now predicts HLA Class I presentation of epitopes with
RapidAI has received FDA clearance for Rapid SDH, its AI-powered module for the detection and notification of suspected hemispheric acute...
Further enhancing comprehensive trauma care solutionÂ
Shared insight into findings of the DETECT-A study, a prospective interventional trial, covering feasibility, safety, and performance of multicancer early detection tests in a healthcare system setting.
Panelists explore recent findings of the PATHFINDER study, focusing on the objectives, study design, key results, and differences from previous studies, shedding light on the potential of early cancer detection tests.